George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

27 Apr 2017 12:57

RNS Number : 5753D
Maven Income and Growth VCT 3 PLC
27 April 2017
 

 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held in 5th Floor, 1-2 Royal Exchange Buildings, London EC3V 3LF on Thursday 27 April 2017 at 10.00 am, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 25 April 2017, the total number of voting rights in the Company stood at 40,930,853 and the total shares in issue were 40,930,853. In accordance with the provisions of E.2.2 of the UK Corporate Governance Code, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 3,774,503 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

3,555,884

207,792

4,887

5,940

3,774,503

2

To approve the Directors' Remuneration Report

3,084,726

207,792

383,960

98,025

3,774,503

3

To approve the Directors' Remuneration Policy

3,044,583

207,792

384,080

138,048

3,774,503

4

To approve a final dividend

3,568,177

206,326

0

0

3,774,503

5

To elect David Allan as a Director

3,482,796

239,515

26,918

25,274

3,774,503

6

To re-elect Atul Devani as a Director

3,494,387

233,452

20,961

25,703

3,774,503

7

To re-elect Bill Nixon as a Director

3,499,749

233,452

19,156

22,146

3,774,503

8

To re-appoint Deloitte LLP as Auditor

3,223,962

225,032

324,266

1,243

3,774,503

9

To authorise the Directors to fix the remuneration of the Auditor

3,523,522

227,237

23,744

0

3,774,503

10

To authorise the Directors to allot new shares

3,520,060

225,032

13,155

16,256

3,774,503

11

To authorise disapplication of pre-emption rights

2,996,202

233,131

412,019

133,151

3,774,503

12

To authorise the Company to purchase its own shares

3,393,524

188,838

184,796

7,345

3,774,503

13

To allow a General Meeting to be called on not less than 14 days' notice

3,421,995

190,792

155,776

5,940

3,774,503

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct3.

 

A copy of the Resolutions passed at the 2017 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

27 April 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGOKODPDBKDAQB
Date   Source Headline
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.